1. Development of adaptive immune effector therapies in solid tumors. (21st August 2019) Authors: Comoli, P; Chabannon, C; Koehl, U; Lanza, F; Urbano-Ispizua, A; Hudecek, M; Ruggeri, A; Secondino, S; Bonini, C; Pedrazzoli, P Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP32 The gut virome-colonizing Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo. (30th January 2023) Authors: Facoetti, A; Massimino, L; Palmieri, O; Fuggetta, D; Spanò, S; D'Alessio, S; Furfaro, F; D'Amico, F; ZIlli, A; Fiorino, G; Noviello, D; Latiano, A; Bossa, F; Pirola, A; Mologni, L; Piazza, R; Abbati, D; Perri, F; Bonini, C; Peyrin-Biroulet, L Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P169 Activated effector T cells co-expressing multiple inhibitory receptors are enriched in the tumor immune microenvironment of HGSOC expressing high and uniform WT-1 antigen. (1st November 2019) Authors: Bergamini, A; Tassi, E; Wignall, J; Ruggiero, E; Bocciolone, L; Candiani, M; Potenza, A; Manfredi, F; Taccagni, G; Scalisi, F; Doglioni, C; Schultes, B; McKee, M; Mangili, G; Bonini, C Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗